Clinical Pharmacology Podcast with Nathan Teuscher

Clinical Pharmacology Podcast with Nathan Teuscher

I discuss clinical pharmacology and pharmacometrics topics from the perspective of drug development scientists. I share my expertise and knowledge about designing and conducting clinical pharmacology studies and discuss how to analyze the data using the most effective approaches. I draw from my experience of over 20 years working in drug development organizations and consultancies.

Tämä podcast on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi podcastin jaksot saattavat sisältää mainontaa.

Jaksot(58)

Different work environments (Ep. 26)

Different work environments (Ep. 26)

Today’s show is about different work environments and not scientific topics. Throughout my career I have worked in many different types of companies, and I would like to share some observations with y...

27 Touko 202435min

Biosimilar products (Ep. 25)

Biosimilar products (Ep. 25)

Today’s show discussed biosimilar development from a clinical pharmacology perspective. I describe what biosimilar products are and the necessary comparisons to the reference product. I review require...

13 Touko 202416min

Choosing an absorption model (Ep. 24)

Choosing an absorption model (Ep. 24)

Today’s show discussed approaches for modeling absorption profiles. I discussed the rationale behind modeling absorption and then described some common models. These included first-order absorption, z...

22 Huhti 202424min

What is Aplos NCA? (Ep. 23)

What is Aplos NCA? (Ep. 23)

Today’s show was an overview of Aplos Analytics and the development story for Aplos NCA. Please consider participating in the Early Access Program. Use the link below to learn more about Aplos NCA. Li...

8 Huhti 202429min

Big announcement and Hepatic impairment studies (Ep. 22)

Big announcement and Hepatic impairment studies (Ep. 22)

Today’s show is about hepatic impairment clinical studies. I cover the rationale behind evaluating hepatic impairment, common study designs, and key factors in the analysis and interpretation of the s...

25 Maalis 202418min

Project Optimus (Ep. 21)

Project Optimus (Ep. 21)

Today’s episode was about Project Optimus, the FDA initiative to improve dose selection and optimization for oncology products. Julie Bullock was a guest on this episode and shared her expertise as a ...

11 Maalis 202439min

Tackling TMDD Models (Ep. 20)

Tackling TMDD Models (Ep. 20)

Today’s show is about TMDD or target-mediated drug disposition models. I review the scientific and physiologic basis for TMDD models, how to review data and determine if a TMDD model is needed. I revi...

26 Helmi 202415min

Communication for scientists (Ep. 19)

Communication for scientists (Ep. 19)

Today’s episode is about communication for scientists. I believe that improvements in communication skills can have a greater impact on your career and work than technical skills. Michael Piperno, an ...

12 Helmi 202446min

Suosittua kategoriassa Tiede

tiedekulma-podcast
rss-poliisin-mieli
rss-mita-tulisi-tietaa
rss-bios-podcast
rss-hereilla
rss-totuuden-liepeilla
utelias-mieli
rss-duodecim-lehti
filocast-filosofian-perusteet
hippokrateen-vastaanotolla
rss-metsanomistaja-podcast
rss-tiedetta-vai-tarinaa
rss-murremyytin-murtajat
rss-astetta-parempi-elama-podcast
rss-sosiopodi